CT-001, a novel fast-clearing factor VIIa, enhanced the hemostatic activity in postpartum samples.
Journal Information
Full Title: Blood Adv
Abbreviation: Blood Adv
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict-of-interest disclosure: D.S.S., C.R.M., T.W.H., and D.B. are employees of and have stock ownerships and stock options in Coagulant Therapeutics. S.L., T.A., J.G., S.-C.K., and A.H.J. received research funding from Coagulant Therapeutics. A.H.J. has received consulting fees from Cerus. T.W.H. is listed as a coinventor on patents filed by Coagulant Therapeutics, related to this study."
Funding Disclosure
Evidence found in paper:
"Coagulant Therapeutics"
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025